Lumenis ResurFX (M22/Stellar module)

Non-Ablative Fractional · 1565nm erbium-glass fractional scanner

Work at Lumenis? — one claim covers all 21 of your devices.
CurrentBe the first to review

Lumenis ResurFX (M22/Stellar module) pricing is not published by the manufacturer, and we have not yet verified a US market range. Lumenis ResurFX (M22/Stellar module) holds FDA 510(k) clearance for its marketed indication. Figures are market estimates verified August 6, 2026.

What it's actually cleared for: Non-ablative fractional 1565nm skin resurfacing (M22 platform)

Last verified: August 6, 2026 · How we verify

New: |Used: market estimate, no email required

Key facts
ManufacturerLumenis
CompanyOwner: Baring Private Equity Asia (BPEA, now part of EQT) (private equity owned, since 2019) · Distribution: direct
CategoryResurfacing, Tattoo & Vascular
Technology1565nm erbium-glass fractional scanner
FDA statusFDA Cleared
New price rangeNot published
Used price rangeNot published
ConsumablesNot published
Launch year2014
Last verifiedAugust 6, 2026
Save device

Overview

True fractional module on M22 family

FDA & regulatory status

Authorized via 510(k)

What it's actually cleared for:

Non-ablative fractional 1565nm skin resurfacing (M22 platform)

510(k) numbers

K170060

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Recent industry events

How we source company data

Ownership and corporate changes at Lumenis that can affect warranty, service and parts availability.

  1. Sep 2021

    Boston Scientific acquires Lumenis surgical unit for $1.07B

    Divestiture

    Boston Scientific acquired the Lumenis surgical/urology business for $1.07B upfront, announced March 3, 2021 and closed September 1, 2021. The aesthetics and ophthalmology businesses were retained by Baring Private Equity Asia and operate as Lumenis Be Ltd.

    Source: Boston Scientific and BPEA press releases

Treatment economics

Economics data for this platform hasn't been published yet.

Chains using this device

No confirmed chain deployments recorded yet.

Owner reviews

Write a review

No verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.

Alternatives

Palomar StarLux (Lux1540/Lux2940)

Non-Ablative Fractional

Solta (Reliant) Fraxel SR750

Non-Ablative Fractional

Solta Clear + Brilliant Touch

Non-Ablative Fractional · $50k–$70k

Lutronic LaseMD Ultra

Non-Ablative Fractional · $60k–$90k

History

Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.

  1. August 1, 2026

    Record created

    Added to The Aesthetic Index — August 2026

    Source: The Aesthetic Index editorial

Get the full State of Aesthetic Devices 2026 report

The first full census of the US aesthetic device market — preview it free.

Get the report